Paclitaxel Enhances Oncolytic Potential of Herpes Simplex Virus Type-1 in Cancer Cells

作者: Misagh Naderi

DOI:

关键词:

摘要:

参考文章(123)
D. Kirn, Oncolytic virotherapy as a novel treatment platform for cancer. Ernst Schering Research Foundation workshop. pp. 89- 105 ,(2003) , 10.1007/978-3-662-05352-2_7
Stacey Efstathiou, Chris M. Preston, Molecular basis of HSV latency and reactivation. Human herpesviruses: biology, therapy, and immunoprophylaxis.. pp. 602- 615 ,(2007)
David S Latchman, Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease. Current Opinion in Molecular Therapeutics. ,vol. 7, pp. 415- ,(2005)
Mary Ann Jordan, Leslie Wilson, Use of drugs to study role of microtubule assembly dynamics in living cells. Methods in Enzymology. ,vol. 298, pp. 252- 276 ,(1998) , 10.1016/S0076-6879(98)98024-7
Matthew Suffness, None, Taxol®: science and applications. (1995). ,(1995)
Chester M. Southam, Alice E. Moore, Induced virus infections in man by the Egypt isolates of West Nile virus. American Journal of Tropical Medicine and Hygiene. ,vol. 3, pp. 19- 50 ,(1954) , 10.4269/AJTMH.1954.3.19
Yukihiro Nishiyama, Herpesvirus genes: molecular basis of viral replication and pathogenicity. Nagoya Journal of Medical Science. ,vol. 59, pp. 107- 119 ,(1996) , 10.18999/NAGJMS.59.3-4.107
F. Guéritte-Voegelein, V. Sénilh, B. David, D. Guénard, P. Potier, Chemical studies of 10-deacetyl baccatin III: Hemisynthesis of taxol derivatives Tetrahedron. ,vol. 42, pp. 4451- 4460 ,(1986) , 10.1016/S0040-4020(01)87285-9